{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:51:50Z","timestamp":1790970710276,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.4065\/80.8.1016","type":"journal-article","created":{"date-parts":[[2009,1,23]],"date-time":"2009-01-23T20:26:10Z","timestamp":1232742370000},"page":"1016-1020","source":"Crossref","is-referenced-by-count":37,"title":["Valvular Heart Disease in Patients Taking Pergolide"],"prefix":"10.4065","volume":"80","author":[{"given":"E. Andrew","family":"Waller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Heckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4065\/80.8.1016_bib1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00002826-199506000-00009","article-title":"Retroperitoneal fibrosis in a patient with Parkinson's disease treated with pergolide","volume":"18","author":"Jimenez-Jimenez","year":"1995","journal-title":"Clin Neuropharmacol"},{"key":"10.4065\/80.8.1016_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/jnnp.66.1.79","article-title":"Pericardial, retroperitoneal, and pleural fibrosis induced by pergolide","volume":"66","author":"Shaunak","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.4065\/80.8.1016_bib3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1378\/chest.120.1.313","article-title":"Pleuropulmonary disease due to pergolide use for restless legs syndrome","volume":"120","author":"Danoff","year":"2001","journal-title":"Chest"},{"key":"10.4065\/80.8.1016_bib4","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/00002826-200209000-00013","article-title":"Pergolide-induced pleuropulmonary fibrosis","volume":"25","author":"Bleumink","year":"2002","journal-title":"Clin Neuropharmacol"},{"key":"10.4065\/80.8.1016_bib5","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/0002-8703(74)90251-8","article-title":"Cardiac murmurs and endocardial fibrosis associated with methysergide therapy","volume":"88","author":"Bana","year":"1974","journal-title":"Am Heart J"},{"key":"10.4065\/80.8.1016_bib6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.7326\/0003-4819-117-1-50","article-title":"Valve disease associated with ergot alkaloid use: echocardiographic and pathologic correlations","volume":"117","author":"Redfield","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.4065\/80.8.1016_bib7","first-page":"235","article-title":"Aortic and mitral valve disease induced by ergotamine therapy for migraine: a case report and review of the literature","volume":"5","author":"Hendrikx","year":"1996","journal-title":"J Heart Valve Dis"},{"key":"10.4065\/80.8.1016_bib8","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00045415-200211000-00005","article-title":"Fibrotic valvular heart disease subsequent to bromocriptine treatment","volume":"10","author":"Serratrice","year":"2002","journal-title":"Cardiol Rev"},{"key":"10.4065\/80.8.1016_bib9","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/01.CIR.92.4.790","article-title":"Carcinoid heart disease: correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography","volume":"92","author":"Robiolio","year":"1995","journal-title":"Circulation"},{"key":"10.4065\/80.8.1016_bib10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199708283370901","article-title":"Valvular heart disease associated with fenfluramine-phentermine [published correction appears in N Engl J Med. 1997;337:1783]","volume":"337","author":"Connolly","year":"1997","journal-title":"N Engl J Med"},{"key":"10.4065\/80.8.1016_bib11","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1161\/01.CIR.102.23.2836","article-title":"Evidence for possible involvement of 5-HT(2B) receptors in cardiac valvulopathy associated with fenfluramine and other serotonergic medications","volume":"102","author":"Rothman","year":"2000","journal-title":"Circulation"},{"key":"10.4065\/80.8.1016_bib12","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1124\/mol.63.6.1223","article-title":"3,4-Methylenedioxy-methamphetamine (MDMA, \u201cEcstasy\u201d) induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro","volume":"63","author":"Setola","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.4065\/80.8.1016_bib13","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.4065\/77.12.1280","article-title":"Valvular heart disease in patients taking pergolide","volume":"77","author":"Pritchett","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/80.8.1016_bib14","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1212\/01.WNL.0000083985.00343.F2","article-title":"Heart valvular disease in patients with Parkinson's disease treated with high-dose pergolide","volume":"61","author":"Van Camp","year":"2003","journal-title":"Neurology"},{"key":"10.4065\/80.8.1016_bib15","doi-asserted-by":"crossref","first-page":"730","DOI":"10.4065\/78.6.730","article-title":"The US Food and Drug Administration's registry of patients with pergolide-associated valvular heart disease","volume":"78","author":"Flowers","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/80.8.1016_bib16","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1161\/01.CIR.76.2.262","article-title":"Age-related valvular regurgitation: a study by pulsed Doppler echocardiography","volume":"76","author":"Akasaka","year":"1987","journal-title":"Circulation"},{"key":"10.4065\/80.8.1016_bib17","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/0002-8703(89)90739-4","article-title":"Prevalence of valvular regurgitation by Doppler echocardiography in patients with structurally normal hearts by two-dimensional echocardiography","volume":"117","author":"Choong","year":"1989","journal-title":"Am Heart J"},{"key":"10.4065\/80.8.1016_bib18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0002-8703(92)90763-L","article-title":"The prevalence of valvular regurgitation in children with structurally normal hearts: a color Doppler echocardiographic study","volume":"123","author":"Brand","year":"1992","journal-title":"Am Heart J"},{"key":"10.4065\/80.8.1016_bib19","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0002-9149(98)01064-9","article-title":"Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study) [published correction appears in Am J Cardiol. 1999;84:1143]","volume":"83","author":"Singh","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.4065\/80.8.1016_bib20","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1067\/mhj.2002.126733","article-title":"Effect of fenfluramine-derivative diet pills on cardiac valves: a meta-analysis of observational studies","volume":"144","author":"Sachdev","year":"2002","journal-title":"Am Heart J"},{"key":"10.4065\/80.8.1016_bib21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0167-5273(01)00412-0","article-title":"Low risk of significant echocardiographic valvulopathy in patients treated with anoretic drugs","volume":"79","author":"Burger","year":"2001","journal-title":"Int J Cardiol"},{"key":"10.4065\/80.8.1016_bib22","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1001\/jama.283.13.1703","article-title":"Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine\/fenfluramine","volume":"283","author":"Gardin","year":"2000","journal-title":"JAMA"},{"key":"10.4065\/80.8.1016_bib23","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/01.CIR.101.17.2071","article-title":"Fenfluramine and phentermine and cardiovascular findings: effect of treatment duration on prevalence of valve abnormalities","volume":"101","author":"Jollis","year":"2000","journal-title":"Circulation"},{"key":"10.4065\/80.8.1016_bib24","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0002-9149(99)00567-6","article-title":"Echocardiographic prevalence of mitral and\/or aortic regurgitation in patients exposed to either fenfluramine-phentermine combination or to dexfenfluramine","volume":"84","author":"Kancherla","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.4065\/80.8.1016_bib25","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0025-6196(11)64213-4","article-title":"Diet drug-related cardiac valve disease: the Mayo Clinic echocardiographic laboratory experience","volume":"75","author":"Teramae","year":"2000","journal-title":"Mayo Clin Proc"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611615838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611615838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T03:23:32Z","timestamp":1545449012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611615838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0025619611615838"],"URL":"https:\/\/doi.org\/10.4065\/80.8.1016","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}